论文部分内容阅读
药品是关系到人体健康的特殊商品,其质量要求显然比一般商品更高更严。近年来,由于《药品管理法》的实施,药品生产、销售、使用单位的药品质量观念明显增强,药品质量也不断提高。但由于药品使用对象广,销售渠道多,目前,假劣药品的严重性还不容忽视。据统计,《药品管理法》实施五年来,全国共查处了近三万起制售假劣药品的违法案件,清理的假劣药价值两亿多元。检验六十多万批次的药品,不合格率达15～20％。广大群众对假劣药品深痛恶绝,一旦发现,普遍要求予以销毁,而厂家和销售单位则倾向“变通使用,以减少国家损失”。 按照《药品管理法》第五十条、五十一条
Drugs are special commodities that have a bearing on human health and their quality requirements are obviously higher and tighter than those of ordinary products. In recent years, due to the implementation of the Drug Administration Law, the concept of quality of medicines in drug production, sales and use units has been significantly enhanced, and the quality of medicines has been continuously improved. However, due to the broad use of drugs, sales channels and more, at present, the seriousness of counterfeit drugs can not be ignored. According to statistics, over the past five years since the implementation of the Drug Administration Law, nearly 30,000 cases of counterfeit and substandard drugs have been investigated and dealt with in the country. The value of counterfeit drugs cleared exceeds 200 million yuan. Test more than 600,000 batches of drugs, failure rate of 15 to 20%. The masses of the public are deeply saddened by counterfeit drugs. Once found, they are generally required to be destroyed. Manufacturers and sales units, on the other hand, tend to “adapt themselves to reduce national losses.” According to Article 50 and Article 51 of the Drug Administration Law